Updated as of JAN-22, 2020
Àλ縻 Çã´ë¼® (´ëÇѾÏÇÐȸ ȸÀå) | 09:30-09:40 | |
1. Microbiome in cancer research and its clinical application | 09:40-11:10 | |
ÁÂÀå: ÇãÈÆ (¾ÆÁÖÀÇ´ë) | ||
1) Understanding microbiome for human health and disease | ±èºÀ¼ö (ÇѸ²´ë ÀÚ¿¬°úÇдë) | |
2) Microbiome data analysis | ¼³¿ìÁØ (Áß¾Ó´ë »ý¸í°øÇдë) | |
3) Role of microbiota in gastric cancer risk | ±èÁ¤¼± (±¹¸³¾Ï¼¾ÅÍ) | |
4) Microbiome meets cancer and immunology | ¹ÚÇѼö (±¤ÁÖ°úÇбâ¼ú¿ø) | |
Coffee Break | 11:10-11:30 | |
2. ÀþÀº ¿¬±¸ÀÚ¸¦ À§ÇÑ ¿¬±¸¹æÇâ ¼ö¸³ | 11:30-13:00 | |
ÁÂÀå: Á¤ÀçÈ£ (¿¬¼¼ÀÇ´ë) | ||
1) À¯Àüü µ¹¿¬º¯ÀÌ ÆÐÅÏ, Mutational signature | ÁÖ¿µ¼® (Çѱ¹°úÇбâ¼ú¿ø) | |
2) ÀÓ»óÀǸ¦ À§ÇÑ ¸é¿ªÇ×¾ÏÁ¦ À¯È¿¼º Æò°¡ | ±èÂù (Â÷ÀÇ´ë) | |
3) ÀÓ»óÀÇ°¡ ÇÏ´Â À§¾Ï Á¾¾ç¹Ì¼¼È¯°æ ¿¬±¸ | ÇãÈÆ (¾ÆÁÖÀÇ´ë) | |
Lunch – ¿ÜºÎ: ´ëÇк»°ü Çлý·±³Á÷¿ø ½Ä´ç (B1) | 13:00-14:00 | |
±âÃÊ¿¬±¸»ç¾÷ ÀÇÇÐºÐ¾ß ºÐ¾ßº° Áö¿øü°è ¼³¸íȸ (À̼®Çü (°¡Å縯ÀÇ´ë)) | 13:40-14:00 | |
3. Cancer proteogenomics | 14:00-15:30 | |
ÁÂÀå: ÀÌ¿¬¼ö (±¹¸³¾Ï¼¾ÅÍ) | ||
1) Proteogenomics analysis of human cancers | Ȳ´ëÈñ (¼¿ï´ë ÀÚ¿¬°úÇдë) | |
2) A comprehensive multi-omics approach for cancer precision medicine: Integrating proteomics and genomics to unlock biological function | ±è±¤Ç¥ (°æÈñ´ë ÀÀ¿ë°úÇдë) | |
3) Proteome-metabolome approaches to identify biomarkers in bloods from lung cancer patients for predicting the response of PD-1 checkpoint inhibitors | À¯º´Ã¶ (±¹¸³¾Ï¼¾ÅÍ) | |
Coffee Break | 15:30-15:50 | |
4. Convergence of AI and immuno-oncology | 15:50-17:20 | |
ÁÂÀå: ÀÌ´ëÈ£ (¿ï»êÀÇ´ë) | ||
1) AI-based prediction of response to IO | À̼¼ÈÆ (¼º±Õ°üÀÇ´ë) | |
2) Deep learning-based profiling of pan-cancer tissues using H&E images | ÆØ°æÇö (·ç´Ö) | |
3) AI and radiology in cancer patients | Á¤¸íÁø (¼º±Õ°üÀÇ´ë) |